Difluprednate

FDA Approved: * August 9, 2021
Pharm Company: * CIPLA
Category: Vision / Eye Health

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Difluprednate Overview

Difluprednate is a corticosteroid, It is chemically a butyrate ester of 6(alpha),9(alpha)-difluoro prednisolone acetate. Accordingly, difluprednate is sometimes abbreviated DFBA, for difluoroprednisolone butyrate acetate. Approval On June 24, 2008, the US Food and Drug Administration (FDA) approved difluprednate for the treatment of post-operative ocular inflammation and pain.[1] It is marketed by Alcon under the tradename Durezol. Clinical trials Difluprednate ophthalmi...

Read more Difluprednate Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Difluprednate

Recent Difluprednate Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Difluprednate
  • Emulsion: 0.05%
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Difluprednate: (2 results)

Sorted by National Drug Code
  • 69097-341 Difluprednate .5 mg/ml Ophthalmic Emulsion by Cipla USA Inc.
  • 69238-1380 Difluprednate .5 mg/ml Ophthalmic Emulsion by Amneal Pharmaceuticals Ny LLC

Other drugs which contain Difluprednate or a similar ingredient: (1 result)